Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Hardy

Showing results (151-160 of 154) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 154 results.
Physical Review Letters|April 17, 2002
Evidence for static magnetism in the vortex cores of ortho-II YBa2Cu3O6.50R I Miller, R F Kiefl, J H Brewer, et al.
European Journal of Pharmacology|December 6, 2001
In vitro activity of LY393558, an inhibitor of the 5-hydroxytryptamine transporter with 5-HT(1B/1D/2) receptor antagonist propertiesI A Pullar, J R Boot, S L Carney, et al.
The Lancet. Respiratory Medicine|April 30, 2022
An online breathing and wellbeing programme (ENO Breathe) for people with persistent symptoms following COVID-19: a parallel-group, single-blind, randomised controlled trialKeir E J Philip, Harriet Owles, Stephanie McVey, et al.
The Lancet. Digital Health|May 8, 2026
An online singing-based breathing and wellbeing programme (ENO Breathe) in people with long COVID breathlessness in the UK: a cohort studyKeir E J Philip, Harriet Owles, Stephanie McVey, et al.
Pageof 16

Showing results (151-160 of 154) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 154 results.
Physical Review Letters|April 17, 2002
Evidence for static magnetism in the vortex cores of ortho-II YBa2Cu3O6.50R I Miller, R F Kiefl, J H Brewer, et al.
European Journal of Pharmacology|December 6, 2001
In vitro activity of LY393558, an inhibitor of the 5-hydroxytryptamine transporter with 5-HT(1B/1D/2) receptor antagonist propertiesI A Pullar, J R Boot, S L Carney, et al.
The Lancet. Respiratory Medicine|April 30, 2022
An online breathing and wellbeing programme (ENO Breathe) for people with persistent symptoms following COVID-19: a parallel-group, single-blind, randomised controlled trialKeir E J Philip, Harriet Owles, Stephanie McVey, et al.
The Lancet. Digital Health|May 8, 2026
An online singing-based breathing and wellbeing programme (ENO Breathe) in people with long COVID breathlessness in the UK: a cohort studyKeir E J Philip, Harriet Owles, Stephanie McVey, et al.
Pageof 16